Author: Nilva Bortoleto
Author: Claudia Cilento
Author: Allan Matsui
Author: Jairo Utimi
Author: Camille Rodrigues da Silva
Good Manufacturing Practices
Unraveling the Abbreviated Development Path
Publication of the Public Consultation for the review of RDC 200 - what is new?
NEW REGULATORY FRAMEWORK OF API
INCREMENTAL INNOVATION: How to prepare for the changes that will come with the revision of RDC 200
COVID-19: What facilities is ANVISA providing at this time of crisis?
Why are 24% of drug registrations still rejected?
Cannabis: challenges and opportunities
NEW API REGULATORY FRAMEWORK: Will ANVISA and international manufacturers be prepared?
Publication of the new API regulatory framework: what is essential to know?
What is important about the new regulatory framework for good manufacturing practices?
Cannabis for therapeutic uses: is this a new market?
DDCM: what are the points that generate the most demands at ANVISA (Part 2)?
New rules for outsourcing in the pharmaceutical industry: many possibilities!
CONTEÚDOS EXCLUSIVOS PARA AUXILIAR EM